UNITED STATES
 SECURITIES AND EXCHANGE COMMISSION
 Washington, D.C. 20549
 ____________________
FORM 8-K
CURRENT REPORT
 Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 18, 2020
THE CLOROX COMPANY
 (Exact name of registrant as specified in its charter)
 ____________________

Delaware		1-07151		31-0595760	
(State or other jurisdiction of
incorporation)		(Commission File Number)		(I.R.S. Employer
Identification No.)	
1221 Broadway, Oakland, California 94612-1888
 (Address of principal executive offices) (Zip code)
(510) 271-7000
 (Registrant's telephone number, including area code)
Not applicable
 (Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[ ]	 	Written communications pursuant to Rule 425 Under the Securities Act (17 CFR 230.425)	
		 	
[ ]		Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)	
		 	
[ ]		Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))	
		 	
[ ]		Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))	
Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading
Symbol(s)	Name of each exchange on which registered	
Common Stock - $1.00 par value	CLX	New York Stock Exchange	
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 	

Item 5.07 Submission of Matters to a Vote of Security Holders.
On November 18, 2020, The Clorox Company (the “Company”) held its virtual annual meeting of shareholders. The matters voted on and the results of the vote were as follows:

1.	The Company’s shareholders elected the following directors to each serve until the next Annual Meeting of Shareholders or until a successor is duly elected and qualified.	
	 	
		Number of Votes	
	     	For	     	Against	     	Abstain	     	Broker Non-Votes	
Amy Banse		89,023,603		302,112		259,772		21,538,945	
Richard H. Carmona		85,307,235		3,797,639		480,613		21,538,945	
Benno Dorer		87,560,509		1,731,105		293,873		21,538,945	
Spencer C. Fleischer		87,246,864		2,033,146		305,477		21,538,945	
Esther Lee		88,980,377		325,623		279,487		21,538,945	
A.D. David Mackay		88,823,687		451,353		310,447		21,538,945	
Paul Parker		88,965,302		304,046		316,139		21,538,945	
Linda Rendle		89,035,194		293,690		256,603		21,538,945	
Matthew J. Shattock		88,708,143		354,382		522,962		21,538,945	
Kathryn Tesija		88,904,660		421,303		259,524		21,538,945	
Pamela Thomas-Graham		84,648,396		4,651,174		285,917		21,538,945	
Russell Weiner		88,773,683		490,423		321,381		21,538,945	
Christopher J. Williams		88,791,577		470,677		323,233		21,538,945	
	 	
2.	The Company’s shareholders voted for (on an advisory basis) the approval of the compensation of the Company’s named executive officers.	
	 	
Number of Votes	
For		Against		Abstain		Broker Non-Votes	
81,237,663	     	7,477,279	     	870,349	     	21,539,141	
	 	
3.	The Company’s shareholders ratified the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending June 30, 2021.	
	 	
Number of Votes	
For		Against		Abstain		Broker Non-Votes	
108,501,462	     	2,269,234	     	353,736	     	0	

	 	
4.	The Company’s shareholders did not approve the proposed amendment to the Company’s Restated Certificate of Incorporation to eliminate the supermajority voting provision. Under the Company’s Restated Certificate of Incorporation, the affirmative vote of at least 80% of the outstanding voting stock is required to approve this proposal. The 88,055,147 votes in favor of this proposal represented 69.86% of the total outstanding shares of common stock.	
	 	
Number of Votes	
For		Against		Abstain		Broker Non-Votes	
88,055,147	     	878,351	     	651,793	     	21,539,141	
Item 8.01 Other Events.
On November 18, 2020, the shareholders of the Company elected Paul Parker to the Board of Directors of the Company. A press release announcing the election of Mr. Parker is filed as Exhibit 99.1 and is incorporated herein in its entirety.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
See the Exhibit Index below.
EXHIBIT INDEX

Exhibit	     	Description	
99.1		Press Release dated November 18, 2020 of The Clorox Company	
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)	

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
THE CLOROX COMPANY

Date:   	November 18, 2020	     	By:  	   /s/ Laura Stein	
				   Executive Vice President –	
				   General Counsel and Corporate Affairs	

PRESS RELEASE		
 	 	
Longtime Finance Leader and Life Sciences Executive Paul Parker Elected to Clorox Board

OAKLAND, Calif., Nov. 18, 2020 – The Clorox Company (NYSE:CLX) announced today that Paul Parker was formally elected to serve on its board of directors. Currently a corporate officer and senior vice president of strategy and corporate development for Thermo Fisher Scientific Inc., he has spent more than three decades within the financial services industry, with a focus on global mergers and acquisitions and investment banking.
“Paul’s deep experience in finance, M&A and strategy will contribute important perspective to the board going forward,” said Clorox lead independent director Pamela Thomas-Graham. “This expertise will be especially valuable as Clorox looks to build on its momentum and support its ambition of accelerating long-term growth.”
At Thermo Fisher, Parker, 57, is responsible for corporate strategy, mergers and acquisitions, corporate social responsibility, government relations, and digital marketing and e-commerce. He previously served as chairman of global M&A at Goldman Sachs & Co. and held senior finance leadership roles at Barclays and Lehman Brothers.
Additional information about The Clorox Company board of directors can be found at www.thecloroxcompany.com.
The Clorox Company
The Clorox Company (NYSE: CLX) is a leading multinational manufacturer and marketer of consumer and professional products with about 8,800 employees worldwide and fiscal year 2020 sales of $6.7 billion. Clorox markets some of the most trusted and recognized consumer brand names, including its namesake bleach and cleaning products; Pine-Sol® cleaners; Liquid-Plumr® clog removers; Poett® home care products; Fresh Step® cat litter; Glad® bags and wraps; Kingsford® charcoal; Hidden Valley® dressings and sauces; Brita® water-filtration products; Burt's Bees® natural personal care products; and RenewLife®, Rainbow Light®, Natural Vitality Calm™, NeoCell® and Stop Aging Now® vitamins, minerals and supplements. The company also markets industry-leading products and technologies for professional customers, including those sold under the CloroxPro™ and Clorox Healthcare® brand names. More than 80% of the company’s sales are generated from brands that hold the No. 1 or No. 2 market share positions in their categories.
Page 1 of 2

Clorox is a signatory of the United Nations Global Compact and the Ellen MacArthur Foundation’s New Plastics Economy Global Commitment. The company has been broadly recognized for its corporate responsibility efforts, listed No. 1 on the 2020 Axios Harris Poll 100 reputation rankings and included on the Barron’s 2020 100 Most Sustainable Companies list and the Human Rights Campaign’s 2020 Corporate Equality Index, among others. In support of its communities, The Clorox Company and its foundations contributed more than $25 million in combined cash grants, product donations and cause marketing in fiscal year 2020. For more information, visit TheCloroxCompany.com, including the Good Growth blog, and follow the company on Twitter at @CloroxCo.

Media Relations
Aileen Zerrudo aileen.zerrudo@clorox.com
Naomi Greer naomi.greer@clorox.com
Investor Relations
Lisah Burhan lisah.burhan@clorox.com
Scott Saul scott.saul@clorox.com
Page 2 of 2